(0.56%) 5 074.75 points
(0.32%) 38 192 points
(0.77%) 17 573 points
(0.68%) $79.54
(2.33%) $1.977
(0.20%) $2 315.70
(-0.22%) $26.69
(0.98%) $964.30
(0.12%) $0.934
(0.33%) $11.07
(0.02%) $0.799
(0.44%) $93.68
Quarter results today
(bmo 2024-05-02)
Expected move: +/- 0.00%
0.76% DKK 132.20
Live Chart Being Loaded With Signals
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. It product portfolio include GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX for treatment of allergic rhinitis and allergic asthma...
Stats | |
---|---|
Volumen de hoy | 145 927 |
Volumen promedio | 276 936 |
Capitalización de mercado | 29.27B |
EPS | DKK0 ( 2024-02-07 ) |
Próxima fecha de ganancias | ( DKK0 ) 2024-06-04 |
Last Dividend | DKK0 ( N/A ) |
Next Dividend | DKK0 ( N/A ) |
P/E | 59.82 |
ATR14 | DKK0.180 (0.14%) |
Volumen Correlación
ALK-Abelló A/S Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
ALK-Abelló A/S Correlación - Moneda/Commodity
ALK-Abelló A/S Finanzas
Annual | 2023 |
Ingresos: | DKK4.82B |
Beneficio Bruto: | DKK3.04B (62.91 %) |
EPS: | DKK2.20 |
FY | 2023 |
Ingresos: | DKK4.82B |
Beneficio Bruto: | DKK3.04B (62.91 %) |
EPS: | DKK2.20 |
FY | 2022 |
Ingresos: | DKK4.51B |
Beneficio Bruto: | DKK2.79B (61.87 %) |
EPS: | DKK1.520 |
FY | 2021 |
Ingresos: | DKK3.92B |
Beneficio Bruto: | DKK2.40B (61.18 %) |
EPS: | DKK1.003 |
Financial Reports:
No articles found.
ALK-Abelló A/S
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. It product portfolio include GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food. It also provides consumer healthcare solution, which include Digital eco-system, a platform which connect and engages with allergy sufferers much earlier in the disease journey through tools and e-commerce offerings that supports, guidance and relief, and smoothing the path to allergy immunotherapy treatment. In addition, the company offers diagnostic allergy solutions through testing by skin prick test or blood test; and emergency treatment, such as intramuscular injection of adrenaline for the treatment of acute life-threatening allergic reactions including Anaphylaxis. ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico